Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
PT JYOTHI DATTA
’
Michael Warmuth, global head of Abbott s pharmaceuticals business.
https://www.thehindubusinessline.com/companies/abbott-to-house-innovation-hub-in-india/article9305643.ece 1/6
2/17/2018 Abbott strengthens India as innovation hub for its pharma business - Business Line
India to house one of company’s six innovation hubs and would feed pharmaceutical
product launches in 30 countries
MUMBAI, NOVEMBER 4
It’s not just about innovating in India for India, but also innovating in India for the rest of the world, says Michael Warmuth, global
head of Abbott’s pharmaceuticals business, on the US healthcare major’s plans to strengthen India as an “innovation hub”.
India will house one of Abbott’s six innovation hubs and would feed pharmaceutical product launches in 30 countries, said Warmuth,
at a breakfast meeting with BusinessLine. “We’re taking a pretty signi cant step forward, we are doubling our scienti c talent here
in India (to 100) . We are moving into a new facility,” he said, possibly by early 2018. The other pharmaceuticals-oriented innovation
hubs are in Singapore, Germany, Columbia, Brazil and Russia.
The new Innovation Development (I&D) hub will be housed in a 10 storey dedicated building in suburban Mumbai, said Bhaskar
Iyer, Head of Abbott’s India operations. With analytical and clinical capabilities, a pilot plant for scale up etc, the facility would
support Abbott’s “established pharmaceuticals” business. “We are no longer dabbling in this area, we’re going into it in a more
signi cant manner to bene t the rest of Abbott pharmaceuticals globally,” says Warmuth.
Products will be tailored to meet unmet needs in the country and aligned to global requirements, he said, adding, “The old model of
the big pharma company that would innovate one solution and then try to push it in every country , it just doesn’t work. So we have
a different view and that’s innovate in India for India.”
Pointing to India’s “frugal innovation” skills (that gets less expensive products quickly into the market), Warmuth said, “We’ve done
a lot of things in the name of innovation historically …..as an industry. We have built solutions that nobody wanted or and couldn’t
afford.” “The idea here is meet the need and do it quickly and move on and do it over and over again. So frugal is a good thing,” he
adds.
Re gu lat or y e nv ironme nt
Commenting on India’s “ uid” or “unpredictable” regulatory environment often cited as a hurdle by foreign companies, Warmuth
says, “The regulators have a role to play, we have a role to play, but in the end, we both work for the same person and that’s the
patient. So the idea that they are trying to change the rule is something that I believe is well intentioned.”
https://www.thehindubusinessline.com/companies/abbott-to-house-innovation-hub-in-india/article9305643.ece 2/6
2/17/2018 Abbott strengthens India as innovation hub for its pharma business - Business Line
However, the regulatory process needs to be more collaborative to bene t the patient, he says. “When I see the policies that are
coming, logic generally prevails but it is a somewhat torturous process,” he says, adding, that too was not unique to India.
Pos t Piramal
The latest research build-up comes six years after Abbott bought Piramal’s domestic formulation drugs business for $ 3.7 billion
(2010). The mandate now is to grow organically, says Warmuth, adding that they are open to acquisition opportunities, again, a
situation not unique to India or the pharmaceuticals business.
Commenting on another development involving Abbott that took place months ago – where a medical representative committed
suicide in Indore -- Warmuth said an employee assistance programme had been instituted. Iyer explained that it involved an
anonymous helpline for employees and their families to get counselling, be it on work-related stress or personal issues. The
incident was a rst in 100-plus years in India, he said, adding that they took it seriously and the assistance programme was part of
their efforts to address stress among employees and their families.
jyothi.datta@thehindu.co.in
Info-box:
India accounts for 20 percent of Abbott’s global pharma sales, at $ 3.7 billion in 2015.
The innovation hub would be supported by its Baddi plant (Himachal Pradesh), also being scaled-up for exports.
Abbott’s traditional therapeutic areas include gastro enterology and womens health.
TO PI C S
Abbott India Ltd pharmaceutical
https://www.thehindubusinessline.com/companies/abbott-to-house-innovation-hub-in-india/article9305643.ece 3/6
2/17/2018 Abbott strengthens India as innovation hub for its pharma business - Business Line
Email Subscribe
Handmade Oil in Kerala to prevent and Buy Term Insurance Before Turning 30: Hilarious Illustrations of Everyday
treat excessive hair loss Experts Married Life That Will Make you Laugh
www.10dayshairoil.com Coverfox Out…
SportzBonanza
Watch Captain America: Civil War on Cable Companies Angry About This Population is important when it comes to
Hotstar Premium Ad-Free Simple Gadget your hair, Fight hair scarcity with this…
Hotstar cool-technology www.m.10dayshairoil.com
https://www.thehindubusinessline.com/companies/abbott-to-house-innovation-hub-in-india/article9305643.ece 4/6
2/17/2018 Abbott strengthens India as innovation hub for its pharma business - Business Line
Credit Cards Offers You Should Not Want Learn To Get The Best Car Insurance 1 year Online course from IIM Indore in
to Miss! Rates Finance
BankBazaar.com Coverfox ICICI Securities
25 Male
No
Rs. 547
0 comments Recommend 0
https://www.thehindubusinessline.com/companies/abbott-to-house-innovation-hub-in-india/article9305643.ece 5/6
2/17/2018 Abbott strengthens India as innovation hub for its pharma business - Business Line
Cauvery water: Setback for TN as Karnataka Time to smoke out malaria from India
gets more... 2 comments
5 comments
GST Council to meet in March to usher... Scam getting bigger by the day: Congress
2 comments 2 comments
Unpublished RBI data shows fraud problems The great bank heist
extend far... 1 comment
2 comments
Vuukle
https://www.thehindubusinessline.com/companies/abbott-to-house-innovation-hub-in-india/article9305643.ece 6/6